Papers
1
Total Citations
57
H-Index
1
About
Dr. Ian Crooks is a leading toxicologist whose research centers on the mutagenic and carcinogenic potential of tobacco products, with a particular focus on next-generation nicotine delivery systems. His most cited work, "The mutagenic assessment of an electronic-cigarette and reference cigarette smoke using the Ames assay" (2016, 57 citations), represents a landmark contribution to the field. In this study, Crooks employed a sophisticated VC 10 smoking robot and a modified 35mm air agar interface methodology to compare the genotoxicity of e-cigarette aerosol with conventional cigarette smoke. His findings demonstrated that e-cigarette aerosol collected matter was non-mutagenic in the Ames assay (strains TA98 and TA100) when tested according to OECD 471 guidelines, providing critical evidence for the reduced-harm potential of vaping products relative to combustible tobacco. This work has been instrumental in shaping regulatory science and public health discussions around tobacco harm reduction. Crooks’ rigorous experimental design and commitment to standardized testing protocols have established him as a trusted voice in toxicological risk assessment, influencing both industry practices and policy frameworks for evaluating novel nicotine products.
Research Focus
Key Achievements
Top Papers
- 1